Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS-24 and SINUS-52 trials.

ABSTRACT:

SUBMITTER: Bachert C 

PROVIDER: S-EPMC9544911 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature